ANTINEO

MEET US IN
SU15
Pdf

ANTINEO

Category

  • Start-up

Location

  • 69008
  • Lyon
  • France

Medias

Activity

  • Antineo is a service company specializing in preclinical therapeutic research in oncology.

Participants

EK avatar

Elsa KRESS

Project Director

Landmarks

  • Turnover : < 2 M€
  • Staff : 0 - 9

Group / Member of

  • Lyonbiopole
  • Mabdesign
  • AFSSI

Objectives

Offers

  •  R&D
  • Technology Platform
  •  Design
  •  Advising and / or services

Needs

Your needs

SPECIFIC INFORMATION ON THE NATURE OF THE OFFER

Antineo accompanies clients in the preclinical development of novel anticancer agents. We provide strategic advice for preclinical development (choice of indications to focus on etc.), and expertise and in vitro, ex vivo and in vivo services aiming at characterising the mode of action and the anti-tumoral efficacy of new drugs.
We have a strong expertise in immunotherapies, and in the development and characterisation of original models for secondary resistances to gold standards.

Your technological assets

  • Devlopment of lymphoma CDX models resistant to rituximab
  • Devlopment of syngeneic models resistant to anti-PD1/PDL1

Application fields

  • Application fields
  • Health - Pharmacy - Biotechnology

EQUIPMENTS, TECHNOLOGIES AND PROCESSES

  • Animal house and authorized personnel
  • multiple colour flow cytometer and immunophenotyping
  • 130 tumour models (CDX and syngeneic)

Certifications

  • CIR 2017-2019

References

Skills

9. Medical and health technologies
  • 9.1 Investigation
  • Biotechnologies
  • 9.2 Therapeutics
  • Drug-screening
  • 9.6 Imaging
  • Data analysis
  • Cellular imaging
  • In vivo imaging
  • 9.8 Modeling
  • Animal models
  • Cellular models